Home

kézbesítés Leíró húsvéti the overall survival was clearly kiegyensúlyozott Hozzájárulás Diktatúra

Current Oncology | Free Full-Text | Population-Based Survival Analysis of  Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major  Histological Subtypes of Cervical Cancer
Current Oncology | Free Full-Text | Population-Based Survival Analysis of Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major Histological Subtypes of Cervical Cancer

Analysis of the Overall survival for IQGAP3 in human cancers. (A) The... |  Download Scientific Diagram
Analysis of the Overall survival for IQGAP3 in human cancers. (A) The... | Download Scientific Diagram

Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma  as determined by bioinformatics analysis
Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis

Oncology Data Advisor - Final Overall Survival Results of the CLEAR Study  in Renal Cell Carcinoma
Oncology Data Advisor - Final Overall Survival Results of the CLEAR Study in Renal Cell Carcinoma

Prognosis of ovarian clear cell cancer compared with other epithelial  cancer types: A population‑based analysis
Prognosis of ovarian clear cell cancer compared with other epithelial cancer types: A population‑based analysis

A Molecular Model for Predicting Overall Survival in Patients with  Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance)  - eBioMedicine
A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance) - eBioMedicine

Frontline Therapy in Advanced Clear Cell RCC: The CLEAR Trial
Frontline Therapy in Advanced Clear Cell RCC: The CLEAR Trial

Decreased expression of JMJD3 predicts poor prognosis of patients with clear  cell renal cell carcinoma
Decreased expression of JMJD3 predicts poor prognosis of patients with clear cell renal cell carcinoma

Oncotarget: Identification intermediate-risk | EurekAlert!
Oncotarget: Identification intermediate-risk | EurekAlert!

Artificial intelligence prediction model for overall survival of clear cell  renal cell carcinoma based on a 21-gene molecular prognostic score system -  Figure f1 | Aging
Artificial intelligence prediction model for overall survival of clear cell renal cell carcinoma based on a 21-gene molecular prognostic score system - Figure f1 | Aging

Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer |  NEJM
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM

Serum Lactate Dehydrogenase Before Nivolumab Treatment Could Be a  Therapeutic Prognostic Biomarker for Patients With Metastatic Clear Cell  Renal Cell Carcinoma | Anticancer Research
Serum Lactate Dehydrogenase Before Nivolumab Treatment Could Be a Therapeutic Prognostic Biomarker for Patients With Metastatic Clear Cell Renal Cell Carcinoma | Anticancer Research

Progression-free survival and overall survival for patients with clear... |  Download Scientific Diagram
Progression-free survival and overall survival for patients with clear... | Download Scientific Diagram

Loss-of-function mutations in PPP2R1A Correlate with Exceptional Survival  in Ovarian Clear Cell Carcinomas Treated with Immune Checkpoint Inhibitors  (099) - ScienceDirect
Loss-of-function mutations in PPP2R1A Correlate with Exceptional Survival in Ovarian Clear Cell Carcinomas Treated with Immune Checkpoint Inhibitors (099) - ScienceDirect

Cancers | Free Full-Text | Evaluation of Survival, Recurrence Patterns and  Adjuvant Therapy in Surgically Staged High-Grade Endometrial Cancer with  Retroperitoneal Metastases
Cancers | Free Full-Text | Evaluation of Survival, Recurrence Patterns and Adjuvant Therapy in Surgically Staged High-Grade Endometrial Cancer with Retroperitoneal Metastases

ASCO 2022: Progression-Free Survival After Second Line of Therapy (PFS-2)  for Metastatic Clear Cell RCC in Patients Treated With First-Line  Immunotherapy Combinations
ASCO 2022: Progression-Free Survival After Second Line of Therapy (PFS-2) for Metastatic Clear Cell RCC in Patients Treated With First-Line Immunotherapy Combinations

A prognostic model for overall survival of patients with early-stage  non-small cell lung cancer: a multicentre, retrospective study - The Lancet  Digital Health
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health

A real-world 1:1 propensity-matched study revealed unmarried status was  independently associated with worse survival for patients with renal clear  cell carcinoma
A real-world 1:1 propensity-matched study revealed unmarried status was independently associated with worse survival for patients with renal clear cell carcinoma

Prognostic value of epithelial-mesenchymal transition markers in clear cell  renal cell carcinoma - Figure f3 | Aging
Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma - Figure f3 | Aging

A Novel Nomogram Predicting the Overall Survival of Patients with  Metastatic Non-clear Cell Renal Cell Carcinoma: A Large Population-Based  Investigation | SpringerLink
A Novel Nomogram Predicting the Overall Survival of Patients with Metastatic Non-clear Cell Renal Cell Carcinoma: A Large Population-Based Investigation | SpringerLink

Figure 1 | Clear Cell Cancer of the Uterine Corpus: The Association of  Clinicopathologic Parameters and Treatment on Disease Progression
Figure 1 | Clear Cell Cancer of the Uterine Corpus: The Association of Clinicopathologic Parameters and Treatment on Disease Progression

ASCO 2023: Final Prespecified Overall Survival Analysis of CLEAR: 4-Year  Follow-up of Lenvatinib + Pembrolizumab vs Sunitinib in Patients with  Advanced RCC
ASCO 2023: Final Prespecified Overall Survival Analysis of CLEAR: 4-Year Follow-up of Lenvatinib + Pembrolizumab vs Sunitinib in Patients with Advanced RCC

Six RNA binding proteins (RBPs) related prognostic model predicts overall  survival for clear cell renal cell carcinoma and is associated with immune  infiltration | Biomolecules and Biomedicine
Six RNA binding proteins (RBPs) related prognostic model predicts overall survival for clear cell renal cell carcinoma and is associated with immune infiltration | Biomolecules and Biomedicine

Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer